I still keep believing that DF won't let any data out until they have double, triple, and quadruple checked it. The last thing they need is to report p21 biomarkers, p53 activation, tumor reduction, etc. and then have something change during the trial to show these early indicators were false. They would never recover from a blunder that large and that is why I feel they will keep everything on the QT until the final report when they have reams of data backing their findings. Such an error would also do irreparable harm to many thousands of patients who may have heard the good news, got their hopes up for a near term cure/remission drug, and then had the rug pulled from beneath their feet.
Early data reporting can only lead to bad things in my opinion and a total data blackout is fully justified. As an investor, I would love to hear great news tomorrow on all these data points but looking at it from the eyes of DF and the patients I have to put their priorities before mine.
News 
Market Data 
Discover 
AI
